Exidavnemab phase 2a study expanded to include MSA patients
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BARNES GROUP, Inc. (NYSE: B) | Delayed: 38.62 -2.14 (5.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.76 | 52 Week High | $44.27 | |||
| Open | $39.35 | 52 Week Low | $30.07 | |||
| Day High | $39.55 | P/E | 29.48 | |||
| Day Low | $38.57 | EPS | $1.31 | |||
| Volume | 2,751,640 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 5.55 +0.04 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.51 | 52 Week High | $8.73 | |||
| Open | $5.45 | 52 Week Low | $2.86 | |||
| Day High | $5.61 | P/E | N/A | |||
| Day Low | $5.41 | EPS | $-3.82 | |||
| Volume | 68,557 | |||||
